Neoadjuvant therapy duration and outcome of patients with resectable and borderline resectable pancreatic ductal adenocarcinoma (PDAC). This is an ASCO Meeting Abstract from the 2019 Gastrointestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback